Skip to main content
Log in

Rosuvastatin and Clinical Outcomes in Individuals Who are not Deemed Appropriate for Baseline Statin Therapy

  • Clinical Trial Report
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Levy WC: Observational studies of statins in systolic heart failure. Heart Fail Clin 2008, 4:201–208.

    Article  PubMed  Google Scholar 

  2. Krum H, Latini R, Maggioni AP, et al.: Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT. Int J Cardiol 2007, 229:48–53.

    Article  Google Scholar 

  3. Kjekshus J, Apetrei E, Barrios V, et al., for the CORONA group: Rosuvastatin in older patients with heart failure. N Engl J Med 2007, 357:2248–2261.

    Article  CAS  PubMed  Google Scholar 

  4. Sander S, Coleman CI, Patel AA, et al.: The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006, 12:464–472.

    Article  CAS  PubMed  Google Scholar 

  5. Rauchhaus M, Clark A, Doehner W, et al.: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003, 42:1933–1940.

    Article  CAS  PubMed  Google Scholar 

  6. Marxcoff L, Thompson P: The role of coenzyme Q10 in statin associated myopathy: a systematic review. J Am Coll Cardiol 2007, 49:2231–2237.

    Article  Google Scholar 

  7. Marchioli R, Levantesi G, Silletta MG, et al.: Effect of n-3 polyunsaturated fatty acids with rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Exp Rev Cardiovasc Ther 2009, 7:735–748.

    Article  CAS  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Clearfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clearfield, M. Rosuvastatin and Clinical Outcomes in Individuals Who are not Deemed Appropriate for Baseline Statin Therapy. Curr Atheroscler Rep 12, 5–7 (2010). https://doi.org/10.1007/s11883-009-0082-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-009-0082-y

Keywords

Navigation